Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Mosquitoes, the Zika virus and the threat for pregnant women: the buzz continues

Over the past months, the Zika virus has been spreading across Middle and South America. Zika has long been considered relatively harmless, but re…


The biggest killer after malaria - How to tackle RSV?

Respiratory syncytial virus (RSV) annually threatens many babies and there is currently no drug or vaccine to combat the disease. A lot of researc…


Halving of new HIV infections by 2030 through better prevention

Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is…

POPULAR TAGS

Hep C drug also active against zika

Written by IL on in the category news with the tags , , .


Scientists from KU Leuven have shown that the experimental antiviral drug 7DMA against hepatitis C slows down the development of the Zika virus in mice. The study, carried out by the Laboratory of Virology and Chemotherapy and led by Prof. Johan Neyts also disposes of a panel of experimental assays to identify inhibitors of the zika virus and an animal model to study zika- infection.
So far no vaccine or antiviral therapies are available for the prevention or treatment of zika infections, which can result in neurological and auto-immune complications in infants and adults.


Reference

Zmurko et al. The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model. PLOS neglected tropical diseases (2016)

 

Read more about: , , .

RELATED ARTICLES
Mosquitoes, the Zika virus and the threat for pregnant women: the buzz continues

Over the past months, the Zika virus has been spreading across Middle and South America. Zika has long been considered relatively harmless, but re…


The biggest killer after malaria - How to tackle RSV?

Respiratory syncytial virus (RSV) annually threatens many babies and there is currently no drug or vaccine to combat the disease. A lot of researc…


Halving of new HIV infections by 2030 through better prevention

Belgium counts more than 1,000 new HIV infections each year, which is a lot compared to other European countries. Fortunately, an HIV infection is…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Janssen Itera Life Science Flanders.bio Biowin V-Bio Ventures Turnstone GSK XpandInnovation UGent KU Leuven

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.